What are the standard first-line treatments for common general practice conditions, including Upper Respiratory Tract Infections (URTI), Acute Bronchitis, Asthma, Hypertension, Type 2 Diabetes Mellitus, Acute Gastroenteritis, Urinary Tract Infections (UTI), and others?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Standard First-Line Treatments for Common General Practice Conditions

The most effective approach to treating common general practice conditions involves using evidence-based first-line medications tailored to specific diagnoses, with antibiotics reserved only for clear bacterial infections.

Upper Respiratory Tract Infections (URTI)

Common Cold/Viral URTI

  • First-line treatment: Supportive care only 1
    • Paracetamol 500-1000mg PO q4-6h PRN for fever/pain (max 4g/day)
    • Dextromethorphan 10-20mg PO q6-8h PRN for dry cough 1
    • Adequate hydration and rest
  • Important: Expectorants, mucolytics, antihistamines, and bronchodilators should NOT be prescribed for acute LRTI in primary care 1

Acute Bronchitis

  • First-line treatment: Primarily supportive care
  • Antibiotics: Generally NOT indicated as most cases are viral 1
  • When to consider antibiotics: Only if high-risk patient (age >75 with fever, cardiac failure, insulin-dependent diabetes, or serious neurological disorder) 1

Pneumonia

  • Diagnosis: Suspect when acute cough plus one of: new focal chest signs, dyspnea, tachypnea, or fever >4 days 1
  • First-line antibiotics: Amoxicillin or tetracycline 1
    • Alternative if hypersensitivity: Macrolides (azithromycin, clarithromycin, erythromycin)
    • Duration: 5-7 days 1

COPD Exacerbation

  • Antibiotics indicated when: All three present: increased dyspnea, increased sputum volume, and increased sputum purulence 1
  • First-line: Amoxicillin or tetracycline 1
  • Alternative: Amoxicillin-clavulanate if high frequency of beta-lactamase producing H. influenzae in the area 1

Asthma

Mild/Moderate Exacerbation

  • First-line:
    • Salbutamol inhaler 2 puffs q4-6h PRN
    • Inhaled corticosteroid (e.g., Budesonide 200mcg BID)
  • For moderate exacerbation: Add oral prednisolone 30-40mg OD x 5 days

Hypertension (Newly Diagnosed/Uncomplicated)

  • First-line: Lifestyle modifications (salt restriction, weight loss, exercise)
  • Medication: Amlodipine 5mg PO OD (if needed)
  • Monitoring: Regular BP checks

Type 2 Diabetes Mellitus (Newly Diagnosed)

  • First-line: Lifestyle modifications (diet, exercise, weight loss)
  • Medication: Metformin 500mg PO OD, titrate up to BID or TID as tolerated
  • Note: Patients with diabetes have increased risk of infections, particularly lower respiratory tract, urinary tract, and skin infections 2

Acute Gastroenteritis

  • First-line:
    • Oral rehydration solution (ORS)
    • Paracetamol for fever
  • Antibiotics: Only if bacterial etiology suspected (bloody diarrhea, high fever)
    • Ciprofloxacin 500mg PO BID x 3-5 days

Urinary Tract Infection (Uncomplicated, Female)

  • First-line antibiotics:
    • Nitrofurantoin 100mg PO BID x 5 days, OR
    • Fosfomycin 3g PO single dose

Skin Infections

Cellulitis

  • First-line: Amoxicillin-Clavulanate 625mg PO TID x 7 days

Impetigo

  • First-line: Topical Mupirocin ointment TID x 5 days

Allergic Rhinitis

  • First-line:
    • Cetirizine 10mg PO OD
    • Fluticasone nasal spray 1-2 sprays/nostril OD

Headache

Tension Headache

  • First-line: Paracetamol 500-1000mg PO q6h PRN

Migraine

  • First-line:
    • Sumatriptan 50mg PO at onset (max 100mg/day)
    • Domperidone 10mg PO TID PRN for nausea

Musculoskeletal Pain

  • First-line:
    • Paracetamol 500-1000mg PO q6h PRN
    • Ibuprofen 400mg PO TID PRN (if no contraindication)
    • Local heat, rest, physiotherapy

Depression/Anxiety (Mild to Moderate)

  • Non-pharmacologic: Counseling, CBT
  • Medication: Escitalopram 10mg PO OD

Dyspepsia/Gastritis

  • First-line: Pantoprazole 40mg PO OD x 2-4 weeks
  • Adjunct: Antacid syrup PRN

Key Considerations for Antibiotic Use

  1. When to suspect pneumonia 1:

    • Acute cough PLUS one of: new focal chest signs, dyspnea, tachypnea, fever >4 days
    • Confirm with chest X-ray if available
  2. When antibiotics are indicated for LRTI 1:

    • Suspected/confirmed pneumonia
    • COPD exacerbation with all three: increased dyspnea, increased sputum volume, increased sputum purulence
    • Age >75 years with fever
    • Cardiac failure
    • Insulin-dependent diabetes
    • Serious neurological disorder
  3. Monitoring response to antibiotics 1:

    • Clinical effects should be expected within 3 days
    • Advise patients to return if no improvement after 3 days
    • For seriously ill patients, follow-up within 2 days

Special Populations

  1. Immunocompromised patients: Higher risk of atypical and severe infections; consider early antibiotic therapy and close monitoring 3

  2. Diabetic patients: Higher risk of respiratory, urinary tract, and skin infections; may require earlier intervention 2

  3. Elderly patients (>65 years): Consider antibiotics more readily, especially with comorbidities 1

Pitfalls to Avoid

  1. Overuse of antibiotics: Most URTIs are viral and self-limiting 4, 5

  2. Inappropriate symptomatic treatments: Expectorants, mucolytics, antihistamines, and bronchodilators are NOT recommended for acute LRTI 1

  3. Delayed treatment of bacterial pneumonia: Can lead to increased morbidity and mortality

  4. Missing high-risk patients: Those >75 years, with comorbidities, or with signs of severe illness may need earlier intervention 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005

Research

Upper respiratory tract infections in the immunocompromised host.

Seminars in respiratory infections, 1995

Research

Tackling upper respiratory tract infections.

The Practitioner, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.